Access to and Predictors of Substance Use Treatment Among People Who are Incarcerated Samuel Chen, MSc; The Pritzker School of Medicine at the University of Chicago
Barriers and Facilitators to Outpatient-Based Opioid Treatment Retention among People Experiencing Homelessness Danielle R. Fine, MD, MSc; Harvard Medical School, Massachusetts General Hospital
A Case-Based Curriculum to Enhance Attitude, Competency, and Knowledge of Buprenorphine for Treatment of Opioid Use Disorder Among Internal Medicine Residents Sebastian Suarez, MD, MPH; Boston University Medical Center
Development of an Ambulatory Addiction Medicine Curricula for Internal Medicine (IM) Residencies at Two Veterans Affairs (VA) Facilities Alyssa Falleni, PharmD, RPh 1,2, Cynthia Frary Mcnamara, MD 2,3,4, Amy J. Kennedy, MD,MS 5; (1) VA Connecticut Healthcare System, (2)Yale School of Medicine, (3)VACT Healthcare System, (4)VA Connecticut Healthcare System, Yale School of Medicine, (5)VA Puget Sound Healthcare System
Developing an Interactive Pharmacy Map of Buprenorphine Access Across Philadelphia Rachel French, PhD, RN; University of Pennsylvania
Distance as a Barrier to Addiction, Mental Health and Primary Care for Persons with Recent Homeless Experience Stefan G. Kertesz, MD, MSc; Heersink UAB School of Medicine
Emergency Medicine Resident Experiences, Perceptions, and Beliefs Regarding Medications for the Treatment of Alcohol Use Disorder Joshua Reed Bia, MD; Yale
Evaluation of a Curriculum on Medication for Opioid Use Disorder for Emergency Medicine Residents Eve Losman, MD, MHSA; University of Michigan
Exploring Patient Perspectives on Care for Hospitalized People Who Use Drugs Margaret Lowenstein, MD, MSHP; University of Pennsylvania
Exploring Sexualized Drug Use, Sexual Behaviors, and Substance Use Among Sexual and Gender Diverse People in California Daryl A. Mangosing, BA, MPH, DrPH; University of California Berkeley
Facing Mortality: Understanding Palliative and End-of-Life Care Needs for Patients with Medical Complexity and Substance Use Disorders Meg Devoe, MD; Oregon Health & Science University
The First Five Years of Missouri’s Medication First Approach to Opioid Use Disorder Treatment: Plateaus, Regressions, and the Underbelly of Progress Rachel Winograd, PhD; University of Missouri-Saint Louis
“Holding Out” in a Holding Cell: Clinical Case Demonstrates a Gap in Access to Medications for Opioid Use Disorder (MOUD) Phoebe A. Cushman, MD, MSc; Spectrum Health Systems, UMass Chan Medical School
Impact of a Medication for Opioid Use Disorder Curriculum for Emergency Medicine Residents Eve Losman, MD, MHSA; University of Michigan
Increasing Buprenorphine Access for Homeless-Experienced Populations Jacob D. Baylis, MPH; University of Utah
Interprofessional Clinician Experiences Caring for Patients With Substance Use Disorders: A Needs Assessment M Holliday Davis 1,2, Margaret Lowenstein, MD, MSHP 3;(1)University of Pennsylvania Center for Addiction Medicine and Policy, (2)Sol Collective, (3)University of Pennsylvania
Interprofessional Perspectives on Caring for Hospitalized Patients with Opioid Use Disorder Margaret Lowenstein, MD, MSHP; University of Pennsylvania
Learning Collaboratives (LCs) in the HEALing Communities Study: A Community- Engaged Training and Technical Assistance (TTA) Approach in a Multi-Community Overdose Reduction Intervention Maria Rudorf, MA; Boston Medical Center
Medication for Opioid Use Disorders (MOUD) Providers’ Perspectives on Working with Drug Courts Ekaterina Pivovarova, PhD; University of Massachusetts Chan Medical School
“One of the Most Complex Medical Problems We Treat in the Hospital”: Hospital Clinician Perspectives on an Inpatient Addiction Consultation Team Madison Rodriguez, BS; University of California, San Francisco
Patients’ Experiences of New Addiction Consultation Service in New York City Public Hospitals Carla King, MPH; NYU Grossman School of Medicine
Private Insurance Failure to Pay: A Major Barrier to Accessing Treatment for Substance Use Disorders Kimber Richter, PhD, MPH; University of Kansas Medical Center
RAMP-UP: Pharmacist-Led Rapid Access to Methadone Maintenance for Patients With Opioid Use Disorder at Penn Pilot Emily R. Casey, PharmD; The Hospital of the University of Pennsylvania
START: A Program to Initiate Substance Use Treatment During Hospitalization for Patients in Texas Alanna Boulton, MHS 1, Richard Bottner, DHA, PA-C, CPHQ, FACHE 2, John Austin Weems-Embers, MD 3, Nicholaus J. Christian, MBA, MD 4; (1)Dell Medical School at The University of Texas at Austin, (2)Colorado Hospital Association, (3)Dell Medical School at the University of Texas at Austin, (4)Yale School of Medicine
A Stigma-Disrupting Core Curriculum Influenced Internal Medicine Residents’ Regard for Patients with Substance Use Disorders Katharine F. Marshall, MD; Northwest Permanente, P.C.
Telemedicine Treatment Retention Characteristics from REACH, a Low Barrier, Community-Based Buprenorphine Clinic in Upstate New York Judith Griffin, MD; The REACH Project, Inc.
The Roles, Activities, and Opportunities of Clinical Pharmacists in a National Initiative to Improve Office-Based Buprenorphine Care Adam J. Gordon, MD; University of Utah School of Medicine
Training Clinicians to Prescribe Buprenorphine for Opioid Use Disorder (OUD) in the Era of Changing Regulations Nikki Kalani Apana, BA, MD Candidate, Irina Kryzhanovskaya, MD; University of California, San Francisco
Trends in Against Medical Advice Discharge and Associations with Inpatient Utilization for Patients with Opioid Use Disorder: A Nation-Wide Cohort Study Ashish P. Thakrar, MD; University of Pennsylvania
Applying a Naloxone Saturation Model in Missouri: Comparing Predictions to Reality Rithvik Kondai, BA; Missouri Institute of Mental Health
Buprenorphine Induction in Emergency Department Patients Following Reversal of Nonfatal Opioid Overdose With Naloxone Samuel Chen, MSc; University of Chicago Pritzker School of Medicine
The Incidence of Buprenorphine Precipitated Withdrawal in ED and Hospitalized Patients with Opioid Use Disorder and Fentanyl Use in Philadelphia: A Retrospective Cohort Study Ashish P. Thakrar, MD; University of Pennsylvania Perelman School of Medicine
Clinicians’ Perceptions and Practices of Urine Drug Testing in Buprenorphine Treatment Isabel H Lamont, BA 1, Mariya Masyukova, MD, MSc 2; (1)Montefiore Hospital/ Albert Einstein College of Medicine, (2)Project Renewal, Inc.
Developing a Computable Phenotype to Identify Opioid Use Disorder in Emergency Department Visits Eve Losman, MD, MHSA; University of Michigan
Development of Scales to Measure the Acceptance of Harm Reduction Zach Budesa, PhD; Missouri Institute of Mental Health
Emergency Physician Perspectives on Harm Reduction and Supporting Patients Who Use Drugs Kathryn A. Dong, FASAM, MD, MSc, Zoe KD Collins, BS; University of Alberta
Identifying Unintentional Fentanyl Exposure Among People Who Have Experienced an Opioid Overdose: A Quality Improvement Investigation from San Francisco Street Overdose Response Team Patrick Low, Medical Student; University of California, San Francisco
The Impact of SHIELD Training on First Responders’ Harm Reduction Attitudes, Beliefs, and Knowledge Saad T. Siddiqui, MPH; Missouri Institute of Mental Health
Implementing Harm Reduction Vending Machines in a California Veterans Affairs Syringe Services Program Tessa Lynne Rife-Pennington, PharmD, BCGP; University of California, San Francisco, School of Pharmacy
The Intersections of Mental Health with Substance Use and Related Barriers to Treatment Among Opioid Overdose Survivors in Boston, MA Ranjani K. Paradise, PhD; Institute for Community Health
Association Between Low-Barrier Access to Methadone in an Outpatient Clinic via the “72 Hour Rule” and Emergency Department Utilization Paul J. Christine, MD, PhD; Boston Medical Center
Low Dose IV Buprenorphine Inductions for Patients with Opioid Use Disorder and Concurrent Pain: A Retrospective Case Series John P. Murray, MA, MD, Geoffrey Pucci, PharmD; University of Chicago
Medical Cannabis and Opioid Use Among Adults with Chronic Pain: Preliminary Results From an 18-month Longitudinal Study Deepika E. Slawek, MD, MPH, MSc; Montefiore Medical Center/Albert Einstein College of Medicine
Medical Students’ Perceived Value of Buprenorphine Waiver Training After Removal of Training Requirement Jared Wilson Klein, MD, MPH; University of Washington; Harborview Medical Center
Nationwide Capabilities Assessment of Emergency Department Care of Patients with Opioid Use Disorder: 2022 to 2023 Kathryn Hawk, MD, MHS; Yale University School of Medicine, Yale University
Outcomes of a Mobile Medical Unit for Low-Threshold Buprenorphine Access Targeting Opioid Overdose Hot Spots in Chicago Elisabeth A. Poorman, MD 1, Sarah Messmer, MD 2; (1)Jesse Brown VA, (2)University of Chicago- Illinois
Patient Perspectives on Transitioning from a Low-Threshold Buprenorphine Program to Clinic-Based Care Noelle G. Martinez, MD, MPH, Megan E Buresh, MD; Johns Hopkins School of Medicine
Piloting a Hospital Rapid Methadone Induction Guideline in the Fentanyl Era Patricia Liu, MD; Oregon Health & Science University
Post-Overdose Outreach Programs in Massachusetts Since the Onset of COVID-19 Alexander Y. Walley, MD, MSc; Boston Medical Center
Associations of Postpartum Opioid Use Disorder Medication Treatment Outcomes With Neighborhood-Level Social Determinants of Health and Prenatal Treatment Receipt Caitlin E. Martin, MD; Virginia Commonwealth University
Associations Between Individual and Hospital-Level Determinants in the Medical Diagnosing of Prenatal Substance Use and Referrals to Child Protection Systems: Multi- level Modeling of a California Birth Cohort Julia Reddy, MA; Gillings School of Global Public Health, University of North Carolina – Chapel Hill
Prescription Opioid Receipt and Dose Change Prior to Fatal Opioid-Involved Overdose Maryam Kazemitabar, PhD; Yale School of Medicine
Prevalence of Fentanyl Analogues in Toxicology Profiles of Emergency Department Patients With Untreated Opioid Use Disorder Ethan Cowan, MD; Icahn School of Medicine at Mount Sinai
A Qualitative Exploration of the Perspectives of School-Based Health Center Staff About Providing Opioid Overdose Prevention Education and Treatment of Opioid Use Disorder Sarah M. Bagley, MD; Boston Medical Center and Chobanian & Avedisian School of Medicine
Rurality and Non-Prescribing Clinicians’ Treatment Orientations and Attitudes Toward Medications for Opioid Use Disorder Aaron R. Brown, LCSW, PhD; University of Kentucky
TA Novel Adaptation of the Project ECHO Model to Convene Leaders in SUD Care Daniel B. Hoover, MD; Oregon Health & Science University